According to a recently published
report, the Global Ophthalmic Drugs Market is expected to grow at the
CAGR of 7% during 2015-2022 and it is estimated to be $XX billion by 2022. The
global ophthalmic drugs market is segmented on the basis of type, therapeutics,
end user applications and geography. The report on global ophthalmic drugs
market forecast 2015-2022 provides detailed overview and predictive
analysis of the market.
The market is driven by various
factors which include increase prevalence of eye related disorders such as
glaucoma and cataract aging population, regulatory approvals to new drugs and
devices, new technologies such as focus on combining drugs and device therapies
and increasing economic factors such as rise in disposable income and health
expenditure in emerging countries such as India and China. The market is
expected to grow at good growth rate due to growing awareness especially in the
emerging and underdeveloped countries. However, factors such as expiration of
patents, drying pipelines and major slowdowns in economies may hamper the market
growth.
Browse Full Report with Toc : http://www.briskinsights.com/report/global-ophthalmic-drugs-market-forecast-2015-2022
The popular drugs include Lucentis,
Eylea, Avastin, Restasis, Lumigan and Ganfort, Xalatan/Xalacom, Pataday and
other. The drugs include drugs for glaucoma, retinal disorder, dry eye,
allergic conjunctivitis, inflammation and conjunctivitis. The end users include
hospitals, eye clinics, diagnostic centres and patients.
The major geographies include North
America, Europe, Asia-Pacific and rest of the world. North America is the
largest market followed by Europe and Asia pacific. The North American market
is driven high awareness, availability of drugs due to presence of major
players. Better regulatory policies have led to increased trust in the drugs.
Asia Pacific market to have high growth rate driven by strong markets in China
and India. Market includes top players such as Abbot Laboratories, ltd,
Allergan Inc, Roche, Pfizer, Novartis, Bayer, Senju, Johnson and Johnson and
Santen.
Browse here for all category Reports : http://www.briskinsights.com/category/pharmaceutical-industry
SCOPE OF THE REPORT
1. Global ophthalmic drugs market By type 2012 – 2022 ($
BILLION)
1.1. Global Prescription ophthalmic
drugs market 2012 – 2022 ($ BILLION)
1.2. Global OTC (over the counter
drugs) ophthalmic drugs market 2012 – 2022 ($ BILLION)
2. Global ophthalmic drugs market by therapeutics 2012 – 2022 ($
BILLION)
2.1. Global Glaucoma ophthalmic drugs
market 2012 – 2022 ($ BILLION)
2.2. Global retinal disorder
ophthalmic drugs market 2012 – 2022 ($ BILLION)
2.3. Global Dry eye ophthalmic drugs
market 2012 – 2022 ($ BILLION)
2.4. Global Allergic conjunctivitis
ophthalmic drugs market 2012 – 2022 ($ BILLION)
3. Global ophthalmic drugs market by end user 2012 – 2022 ($
BILLION)
3.1. Global Hospitals ophthalmic drugs
market 2012 – 2022 ($ BILLION)
3.2. Global Eye clinics ophthalmic
drugs market 2012 – 2022 ($ BILLION)
3.3. Global Diagnostic centers
ophthalmic drugs market 2012 – 2022 ($ BILLION)
3.4. Global Patients ophthalmic drugs
market 2012 – 2022 ($ BILLION)
4. Global ophthalmic drugs market regional outlook 2012-2022 ($ billion)
4.1. North America
4.2. Europe
4.3. Asia Pacific
4.4. Middle East & Africa
4.5. Central & South America
For Other Research Reports :
http://www.briskinsights.com/report/contraceptive-market
About Us :
Brisk Insights is a global market
research firm. Our insightful analysis is focused on developed and emerging
markets. We identify trends and forecast markets with a view to aid businesses
identify market opportunities optimize strategies.
Working in a highly dynamic and
multi-dimensional business makes decision making complex. Effective business
decisions are a result of the synthesis of market information. Our Research and
data analysis is an efficient and cost-effective way of providing robust market
analysis and can yield highly valuable intelligence relating to consumers,
competitors and markets.
Contact Us :
Jennifer Smith
Office 1094
109 Vernon House
Friar Lane
Nottingham
NG1 6DQ
Phone : +448081890034 (UK)
Email : sales@briskinsights.com
Website : http://www.briskinsights.com/